2018 was a busy and productive year for ACRO’s European Scientific & Regulatory Committee, which meets quarterly in London. While the Committee focused largely on the continuing implementation of the EU Clinical Trial Regulation, there were also opportunities to engage with regulators on other topics ranging from European regulatory strategy to Advanced Therapies to the urgent challenges of Brexit.
Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Dr. Cynthia Verst,…
The Association of Clinical Research Organizations (ACRO) convenes discussion series that seeks to advance an industry with important health and economic impacts…
What happens to clinical research when the UK leaves the EU’s common market and regulatory structure? When public perceptions seem locked onto…
ACRO joins FDA public meeting to discuss trial risks and rationale, benefits and barriers Clinical trials have an enormous number of inter-related,…
In May of 2017 the Board of Directors of the Association of Clinical Research Organizations, which represents the world’s leading clinical research…
The Association of Clinical Research Organizations (ACRO) highlights contributions to health and economy (Leeds, UK) – Facing unprecedented challenges associated with Brexit,…
WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected John Ratliff, CEO of Covance Drug…
WASHINGTON – November 14, 2017 – As the Senate begins debate on a tax reform bill, the clinical research industry hopes that…
Washington, DC – October 24, 2017 – On October 19 ACRO Executive Director Doug Peddicord, Ph.D., testified at a public hearing of…
WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) applauds Research!America for a recently released survey on the public’s perception of clinical trials….
Over the past few years, legislation that would give terminally ill patients access to unapproved treatments, known as “Right-to-Try,” has gained momentum…
Contact: John Lewis 202.464.9340 jlewis@acrohealth.org April 4, 2017 (Washington, DC) – The Domestic Research Enhancement Act of 2017 (H.R. 1234), which modernizes…
February 21, 2017 Dr. Francis S. Collins Director, National Institutes of Health Dr. Patricia Flatley Brennan Director, National Library of Medicine Re:…
Contact: John Lewis 202.464.9340 jlewis@acrohealth.org John Hubbard of Bioclinica Elected 2017 ACRO Chairman Medidata Joins Member Companies January 30, 2017 – WASHINGTON,…
Contact: John Lewis 202.464.9340 jlewis@acrohealth.org December 7, 2016 (Washington, DC) – Doug Peddicord, PhD, Executive Director of the Association of Clinical Research…
Contact: John Lewis 202.464.9340 jlewis@acrohealth.org May 10, 2016 (Washington, DC) – A rapid increase in the use of wearable technology and an…
February 9, 2016 – WASHINGTON, DC – The Association of Clinical Research Organizations (ACRO) today launched a new video series examining the…
January 6, 2016 – WASHINGTON, DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of…
Washington, D.C. – The Association of Clinical Research Organizations (ACRO), is very pleased to name its two 2015 Legislators of the Year,…